Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Busulfan × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 31 Myelodysplastic Syndromes 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia 8 Hematologic Neoplasms 8 Anemia, Refractory, with Excess of Blasts 8 Myeloproliferative Disorders 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Hodgkin Disease 7 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Neuroblastoma 5 Graft vs Host Disease 5 Primary Myelofibrosis 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Myeloid 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precancerous Conditions 3 Lymphoproliferative Disorders 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphoid 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Anemia, Aplastic 3 Wilms Tumor 2 Sarcoma, Ewing 2

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡